α-synuclein genetic variability: A biomarker for dementia in Parkinson disease
Objective<br/> The relationship between Parkinson disease (PD), PD with dementia (PDD), and dementia with Lewy bodies (DLB) has long been debated. Although PD is primarily considered a motor disorder, cognitive impairment is often present at diagnosis, and only ∼20% of patients remain cognitiv...
Main Authors: | Guella, I, Evans, D, Szu-Tu, C, Nosova, E, Bortnick, S, Goldman, J, Dalrymple-Alford, J, Geurtsen, G, Litvan, I, Ross, O, Middleton, L, Parkkinen, L, Farrer, M |
---|---|
Formato: | Journal article |
Publicado: |
Wiley
2016
|
Títulos similares
-
Mild cognitive impairment as a risk factor for Parkinson's disease dementia
por: Hoogland, J, et al.
Publicado: (2017) -
Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia
por: Parkkinen, L, et al.
Publicado: (2004) -
The significance of α-Synuclein, Amyloid-β and Tau pathologies in Parkinson's disease progression and related dementia
por: Compta, Y, et al.
Publicado: (2013) -
Risk of Parkinson's disease dementia related to level I MDS PD-MCI
por: Hoogland, J, et al.
Publicado: (2019) -
A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism
por: Adam Book, et al.
Publicado: (2018-12-01)